https://scholars.lib.ntu.edu.tw/handle/123456789/510019
標題: | Multicenter study of azole-resistant aspergillus fumigatus clinical isolates, Taiwan | 作者: | Wu, Chi Jung Liu, Wei Lun Lai, Chih Cheng Chao, Chien Ming Ko, Wen Chien Wang, Hsuan Chen Dai, Ching Tzu Hsieh, Ming I. Choi, Pui Ching Yang, Jia Ling YEE-CHUN CHEN |
公開日期: | 1-四月-2020 | 出版社: | CENTERS DISEASE CONTROL & PREVENTION | 卷: | 26 | 期: | 4 | 起(迄)頁: | 806 | 來源出版物: | Emerging Infectious Diseases | 摘要: | © 2020 Centers for Disease Control and Prevention (CDC). All rights reserved. In a multicenter study, we determined a prevalence rate of 4% for azole-resistant Aspergillus fumigatus in Taiwan. Resistance emerged mainly from the environment (TR34/ L98H, TR34/L98H/S297T/F495I, and TR46/Y121F/T289A mutations) but occasionally during azole treatment. A high mortality rate observed for azole-resistant aspergillosis necessitates diagnostic stewardship in healthcare and antifungal stewardship in the environment. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/510019 | ISSN: | 10806040 | DOI: | 10.3201/eid2604.190840 | SDG/關鍵字: | cdr1b protein; difenoconazole; fungal protein; high mobility group B1 protein; pyrrole; sterol 14alpha demethylase; tebuconazole; unclassified drug; voriconazole; antifungal agent; fungal protein; pyrrole derivative; antifungal resistance; antifungal susceptibility; Article; aspergillosis; Aspergillus fumigatus; bacterium isolation; cross resistance; fungal colonization; gene mutation; genotype; human; lung aspergillosis; major clinical study; mortality rate; nonhuman; phylogeny; prevalence; Taiwan; antifungal resistance; Aspergillus fumigatus; clinical trial; epidemiology; genetics; microbial sensitivity test; multicenter study; Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Taiwan |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。